Biotechnology
Gilead Sciences battles U.S. government in court over HIV prevention patent
Gilead Sciences logo displayed on a laptop screen and medical pills are seen in this illustration photo taken in Krakow, Poland on October 18, 2021. (Photo by Jakub Porzycki/NurPhoto via Getty Images) Nurphoto | Nurphoto | Getty Images Gilead Sciences and the U.S. government faced off in court Tuesday in the first day of a […]
Read More
Pfizer earnings and revenue top expectations despite Covid vaccine sales decline
Pharmaceutical Pfizer Inc. said that an oral drug for treating COVID-19 could be available by end of 2021. Soumyabrata Roy | NurPhoto | Getty Images Pfizer on Tuesday reported first-quarter revenue and adjusted earnings that topped Wall Street’s expectations, despite a decline in sales driven by the lower demand for the company’s Covid vaccine. Pfizer’s […]
Read More
Biden will end Covid vaccine mandates for federal workers and international travelers on May 11
Travelers wearing protective masks receive nasal swabs from nurses at a COVID-19 test site inside Terminal B at Los Angeles International Airport (LAX), on Sunday, Nov. 22, 2020. Bing Guan | Bloomberg | Getty Images The Biden administration will end its Covid-19 vaccine mandates for federal employees, contractors and international air travelers next week. The […]
Read More
Bipartisan attorneys general call on Medicare to cover Alzheimer’s treatments
The Alzheimer’s drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai | via Reuters Democratic and Republican attorneys general in nearly half of U.S. states are calling on Medicare to provide unrestricted coverage of antibody treatments for Alzheimer’s disease, according to a letter released Monday. The push […]
Read More
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
Juanmonino | E+ | Getty Images Seniors with early Alzheimer’s disease will face major hurdles to get treated even if promising new drugs roll out more broadly in the coming years, putting them at risk of developing more severe disease as they wait months or perhaps years for a diagnosis. The U.S. health-care system is […]
Read More
Carl Icahn calls Illumina Q1 results ‘very disappointing,’ slams cost-cutting plan
Carl Icahn speaking at Delivering Alpha in New York on Sept. 13, 2016. David A. Grogan | CNBC Carl Icahn on Friday called Illumina’s first-quarter results “very disappointing” and slammed the DNA sequencing company’s new plans to cut costs. The activist investor, who owns a 1.4% stake in Illumina, is in a heated proxy fight […]
Read More
Being overweight drug marketplace could be really worth $200 billion in the decade, states Barclays, as sector valuations grow
The burgeoning pounds-decline drug market, which is whetting investors’ appetites with its pledge of combatting worldwide being overweight rates, could be value as a great deal as $200 billion inside of the following decade, in accordance to Barclays lender. Dubbing being overweight “the story of this ten years,” Barclays’ head of European pharmaceuticals fairness investigation […]
Read More
Abortion pill mifepristone is banned or restricted in some states despite Supreme Court ruling
In this photo illustration, packages of Mifepristone tablets are displayed at a family planning clinic on April 13, 2023 in Rockville, Maryland. Anna Moneymaker | Getty Images The abortion pill mifepristone is either banned or restricted to varying degrees in 27 states despite a Supreme Court decision that — for now — maintains Food and […]
Read More
Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds
A pharmacist displays a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and made by Lilly at Rock Canyon Pharmacy in Provo, Utah, May 29, 2023. George Frey | Reuters Patients who took Eli Lilly‘s weight loss drug tirzepatide lost up to 34 pounds on average, or 16% of their […]
Read More
Il Makiage parent Oddity buys biotech startup Revela to design new molecules for beauty products
The beauty and wellness platform behind Il Makiage and Spoiled Child is investing more than $100 million to acquire a biotech startup and open a U.S.-based lab in a bid to make the most effective cosmetic products on the market, the company announced Thursday. Oddity is buying startup Revela for $76 million, its largest acquisition […]
Read More